0

Purchase Short-Term Access

The Risk for Myocardial Infarction with Cyclooxygenase-2 Inhibitors
Michal R. Pijak, MD; Igor Huzicka, MD; Frantisek Gazdik, MD, PhD
Annals of Internal Medicine 2005;143:616-617. doi:10.7326/0003-4819-143-8-200510180-00021

Purchase Online access to this article for 24 hours
Buy Now
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)